Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...

Wastewater surveillance suggests that we in the midst of what's being called a "Silent" COVID-19 surge fueled by the XEC ...

The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, ...

MTX-COVAB is under clinical development by Memo Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Omeros is putting up its monoclonal antibody up for FDA approval—again. | Omeros is putting up its monoclonal antibody up for ...

Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.

Press Release - Vaccination remains an important public health countermeasure against COVID-19. As per the WHO Director ...

The U.S. Food and Drug Administration has revoked the Emergency Use Authorization for bamlanivimab administered alone, bamlanivimab and ...

The US Food and Drug Administration (USFDA) has revoked the emergency use authorisation for four Covid-19 antibody-based ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity — primarily organ ...

An MOH spokesman said that in general, the Covid-19 situation here has been stable. Read more at straitstimes.com.